Sign In

Login

Password

Forgot Password ? Sign Up

Resistina (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Resistina" in Spanish language version.

refsWebsite
Global rank Spanish rank
38nih.gov
4th place
4th place
35doi.org
2nd place
2nd place
2web.archive.org
1st place
1st place
1elsevier.com
610th place
332nd place
1bloodjournal.org
low place
low place
1harvard.edu
18th place
34th place

bloodjournal.org

doi.org

dx.doi.org

  • Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (enero de 2001). «The hormone resistin links obesity to diabetes». Nature 409 (6818): 307-12. PMID 11201732. doi:10.1038/35053000. 
  • Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Watson W, Kerr K, Jones R, Zhu Q, Considine RV (noviembre de 2003). «Serum resistin (FIZZ3) protein is increased in obese humans». J. Clin. Endocrinol. Metab. 88 (11): 5452-5. PMID 14602788. doi:10.1210/jc.2002-021808. 
  • Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH, Scherer P, Rossetti L, Barzilai N (octubre de 2002). «Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?». Diabetes 51 (10): 2951-8. PMID 12351432. doi:10.2337/diabetes.51.10.2951. 
  • Levy JR, Davenport B, Clore JN, Stevens W (marzo de 2002). «Lipid metabolism and resistin gene expression in insulin-resistant Fischer 344 rats». Am. J. Physiol. Endocrinol. Metab. 282 (3): E626-33. PMID 11832366. doi:10.1152/ajpendo.00346.2001. 
  • McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S (enero de 2002). «Resistin, central obesity, and type 2 diabetes». Lancet 359 (9300): 46-7. PMID 11809189. doi:10.1016/S0140-6736(02)07281-1. 
  • Adeghate E (octubre de 2004). «An update on the biology and physiology of resistin». Cell. Mol. Life Sci. 61 (19-20): 2485-96. PMID 15526156. doi:10.1007/s00018-004-4083-2. 
  • Stumvoll M, Häring H (noviembre de 2002). «Resistin and adiponectin--of mice and men». Obes. Res. 10 (11): 1197-9. PMID 12429885. doi:10.1038/oby.2002.162. 
  • Vendrell J, Broch M, Vilarrasa N, Molina A, Gómez JM, Gutiérrez C, Simón I, Soler J, Richart C (junio de 2004). «Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity». Obes. Res. 12 (6): 962-71. PMID 15229336. doi:10.1038/oby.2004.118. 
  • Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale FV Jr, Shelton DL, Hébert CC (agosto de 2000). «FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family». EMBO J. 19 (15): 4046-55. PMC 306596. PMID 10921885. doi:10.1093/emboj/19.15.4046. 
  • Kusminski CM, da Silva NF, Creely SJ, Fisher FM, Harte AL, Baker AR, Kumar S, McTernan PG (enero de 2007). «The in vitro effects of resistin on the innate immune signaling pathway in isolated human subcutaneous adipocytes». J. Clin. Endocrinol. Metab. 92 (1): 270-6. PMID 17062773. doi:10.1210/jc.2006-1151. 
  • Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M (diciembre de 2006). «Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients». Transplant. Proc. 38 (10): 3434-6. PMID 17175295. doi:10.1016/j.transproceed.2006.10.140. 
  • Nagaev I, Bokarewa M, Tarkowski A, Smith U (2006). «Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes». PLoS ONE 1: e31. PMC 1762367. PMID 17183659. doi:10.1371/journal.pone.0000031. 
  • Milan G, Granzotto M, Scarda A, Calcagno A, Pagano C, Federspil G, Vettor R (noviembre de 2002). «Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss». Obes. Res. 10 (11): 1095-103. PMID 12429872. doi:10.1038/oby.2002.149. 
  • Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ (septiembre de 2005). «Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway». Biochem. Biophys. Res. Commun. 334 (4): 1092-101. PMID 16039994. doi:10.1016/j.bbrc.2005.06.202. 
  • Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA (agosto de 2003). «Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction». Circulation 108 (6): 736-40. PMID 12874180. doi:10.1161/01.CIR.0000084503.91330.49. 
  • Lu SC, Shieh WY, Chen CY, Hsu SC, Chen HL (octubre de 2002). «Lipopolysaccharide increases resistin gene expression in vivo and in vitro». FEBS Lett. 530 (1-3): 158-62. PMID 12387885. doi:10.1016/S0014-5793(02)03450-6. 
  • Wellen KE, Hotamisligil GS (mayo de 2005). «Inflammation, stress, and diabetes». J. Clin. Invest. 115 (5): 1111-9. PMC 1087185. PMID 15864338. doi:10.1172/JCI25102. 
  • Wulster-Radcliffe MC, Ajuwon KM, Wang J, Christian JA, Spurlock ME (abril de 2004). «Adiponectin differentially regulates cytokines in porcine macrophages». Biochem. Biophys. Res. Commun. 316 (3): 924-9. PMID 15033490. doi:10.1016/j.bbrc.2004.02.130. 
  • Axelsson J, Bergsten A, Qureshi AR, Heimbürger O, Bárány P, Lönnqvist F, Lindholm B, Nordfors L, Alvestrand A, Stenvinkel P (febrero de 2006). «Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance». Kidney Int. 69 (3): 596-604. PMID 16395259. doi:10.1038/sj.ki.5000089. 
  • Asensio C, Cettour-Rose P, Theander-Carrillo C, Rohner-Jeanrenaud F, Muzzin P (mayo de 2004). «Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis». Endocrinology 145 (5): 2206-13. PMID 14962997. doi:10.1210/en.2003-1679. 
  • Lee JH, Bullen JW, Stoyneva VL, Mantzoros CS (marzo de 2005). «Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia». Am. J. Physiol. Endocrinol. Metab. 288 (3): E625-32. PMID 15522996. doi:10.1152/ajpendo.00184.2004. 
  • Valsamakis G, McTernan PG, Chetty R, Al Daghri N, Field A, Hanif W, Barnett AH, Kumar S (abril de 2004). «Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines». Metab. Clin. Exp. 53 (4): 430-4. PMID 15045687. doi:10.1016/j.metabol.2003.11.022. 
  • McTernan PG, McTernan CL, Chetty R, Jenner K, Fisher FM, Lauer MN, Crocker J, Barnett AH, Kumar S (mayo de 2002). «Increased resistin gene and protein expression in human abdominal adipose tissue». J. Clin. Endocrinol. Metab. 87 (5): 2407. PMID 11994397. doi:10.1210/jc.87.5.2407. 
  • Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS (noviembre de 2002). «A central role for JNK in obesity and insulin resistance». Nature 420 (6913): 333-6. PMID 12447443. doi:10.1038/nature01137. Archivado desde el original el 21 de abril de 2008. 
  • Rajala MW, Qi Y, Patel HR, Takahashi N, Banerjee R, Pajvani UB, Sinha MK, Gingerich RL, Scherer PE, Ahima RS (julio de 2004). «Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting». Diabetes 53 (7): 1671-9. PMID 15220189. doi:10.2337/diabetes.53.7.1671. 
  • Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ (octubre de 2003). «Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance». Eur. J. Endocrinol. 149 (4): 331-5. PMID 14514348. doi:10.1530/eje.0.1490331. 
  • Smith SR, Bai F, Charbonneau C, Janderová L, Argyropoulos G (julio de 2003). «A promoter genotype and oxidative stress potentially link resistin to human insulin resistance». Diabetes 52 (7): 1611-8. PMID 12829623. doi:10.2337/diabetes.52.7.1611. 
  • Fujinami A, Obayashi H, Ohta K, Ichimura T, Nishimura M, Matsui H, Kawahara Y, Yamazaki M, Ogata M, Hasegawa G, Nakamura N, Yoshikawa T, Nakano K, Ohta M (enero de 2004). «Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes». Clin. Chim. Acta 339 (1-2): 57-63. PMID 14687894. doi:10.1016/j.cccn.2003.09.009. 
  • McTernan PG, Fisher FM, Valsamakis G, et al. (diciembre de 2003). «Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes». J. Clin. Endocrinol. Metab. 88 (12): 6098-106. PMID 14671216. doi:10.1210/jc.2003-030898. 
  • Fain JN, Cheema PS, Bahouth SW, Lloyd Hiler M (enero de 2003). «Resistin release by human adipose tissue explants in primary culture». Biochem. Biophys. Res. Commun. 300 (3): 674-8. PMID 12507502. doi:10.1016/S0006-291X(02)02864-4. 
  • Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Estrada E, Seip R, Orlova C, Mantzoros CS (octubre de 2003). «Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects». J. Clin. Endocrinol. Metab. 88 (10): 4848-56. PMID 14557464. doi:10.1210/jc.2003-030519. 
  • Nagaev I, Smith U (julio de 2001). «Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle». Biochem. Biophys. Res. Commun. 285 (2): 561-4. PMID 11444881. doi:10.1006/bbrc.2001.5173. 
  • Heilbronn LK, Rood J, Janderova L, Albu JB, Kelley DE, Ravussin E, Smith SR' (abril de 2004). «Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects». J. Clin. Endocrinol. Metab. 89 (4): 1844-8. PMID 15070954. doi:10.1210/jc.2003-031410. 
  • Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O'Rahilly S (octubre de 2001). «Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans». Diabetes 50 (10): 2199-202. PMID 11574398. doi:10.2337/diabetes.50.10.2199. 
  • Way JM, Görgün CZ, Tong Q, Uysal KT, Brown KK, Harrington WW, Oliver WR Jr, Willson TM, Kliewer SA, Hotamisligil GS (julio de 2001). «Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists». J. Biol. Chem. 276 (28): 25651-3. PMID 11373275. doi:10.1074/jbc.C100189200. 

elsevier.com

linkinghub.elsevier.com

harvard.edu

hsph.harvard.edu

nih.gov

ncbi.nlm.nih.gov

  • Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (enero de 2001). «The hormone resistin links obesity to diabetes». Nature 409 (6818): 307-12. PMID 11201732. doi:10.1038/35053000. 
  • Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Watson W, Kerr K, Jones R, Zhu Q, Considine RV (noviembre de 2003). «Serum resistin (FIZZ3) protein is increased in obese humans». J. Clin. Endocrinol. Metab. 88 (11): 5452-5. PMID 14602788. doi:10.1210/jc.2002-021808. 
  • Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH, Scherer P, Rossetti L, Barzilai N (octubre de 2002). «Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?». Diabetes 51 (10): 2951-8. PMID 12351432. doi:10.2337/diabetes.51.10.2951. 
  • Levy JR, Davenport B, Clore JN, Stevens W (marzo de 2002). «Lipid metabolism and resistin gene expression in insulin-resistant Fischer 344 rats». Am. J. Physiol. Endocrinol. Metab. 282 (3): E626-33. PMID 11832366. doi:10.1152/ajpendo.00346.2001. 
  • McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S (enero de 2002). «Resistin, central obesity, and type 2 diabetes». Lancet 359 (9300): 46-7. PMID 11809189. doi:10.1016/S0140-6736(02)07281-1. 
  • Adeghate E (octubre de 2004). «An update on the biology and physiology of resistin». Cell. Mol. Life Sci. 61 (19-20): 2485-96. PMID 15526156. doi:10.1007/s00018-004-4083-2. 
  • Stumvoll M, Häring H (noviembre de 2002). «Resistin and adiponectin--of mice and men». Obes. Res. 10 (11): 1197-9. PMID 12429885. doi:10.1038/oby.2002.162. 
  • Vendrell J, Broch M, Vilarrasa N, Molina A, Gómez JM, Gutiérrez C, Simón I, Soler J, Richart C (junio de 2004). «Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity». Obes. Res. 12 (6): 962-71. PMID 15229336. doi:10.1038/oby.2004.118. 
  • Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale FV Jr, Shelton DL, Hébert CC (agosto de 2000). «FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family». EMBO J. 19 (15): 4046-55. PMC 306596. PMID 10921885. doi:10.1093/emboj/19.15.4046. 
  • Kusminski CM, da Silva NF, Creely SJ, Fisher FM, Harte AL, Baker AR, Kumar S, McTernan PG (enero de 2007). «The in vitro effects of resistin on the innate immune signaling pathway in isolated human subcutaneous adipocytes». J. Clin. Endocrinol. Metab. 92 (1): 270-6. PMID 17062773. doi:10.1210/jc.2006-1151. 
  • Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M (diciembre de 2006). «Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients». Transplant. Proc. 38 (10): 3434-6. PMID 17175295. doi:10.1016/j.transproceed.2006.10.140. 
  • Nagaev I, Bokarewa M, Tarkowski A, Smith U (2006). «Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes». PLoS ONE 1: e31. PMC 1762367. PMID 17183659. doi:10.1371/journal.pone.0000031. 
  • Milan G, Granzotto M, Scarda A, Calcagno A, Pagano C, Federspil G, Vettor R (noviembre de 2002). «Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss». Obes. Res. 10 (11): 1095-103. PMID 12429872. doi:10.1038/oby.2002.149. 
  • Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ (septiembre de 2005). «Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway». Biochem. Biophys. Res. Commun. 334 (4): 1092-101. PMID 16039994. doi:10.1016/j.bbrc.2005.06.202. 
  • Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA (agosto de 2003). «Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction». Circulation 108 (6): 736-40. PMID 12874180. doi:10.1161/01.CIR.0000084503.91330.49. 
  • Lu SC, Shieh WY, Chen CY, Hsu SC, Chen HL (octubre de 2002). «Lipopolysaccharide increases resistin gene expression in vivo and in vitro». FEBS Lett. 530 (1-3): 158-62. PMID 12387885. doi:10.1016/S0014-5793(02)03450-6. 
  • Wellen KE, Hotamisligil GS (mayo de 2005). «Inflammation, stress, and diabetes». J. Clin. Invest. 115 (5): 1111-9. PMC 1087185. PMID 15864338. doi:10.1172/JCI25102. 
  • Wulster-Radcliffe MC, Ajuwon KM, Wang J, Christian JA, Spurlock ME (abril de 2004). «Adiponectin differentially regulates cytokines in porcine macrophages». Biochem. Biophys. Res. Commun. 316 (3): 924-9. PMID 15033490. doi:10.1016/j.bbrc.2004.02.130. 
  • Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Tenner AJ, Tomiyama Y, Matsuzawa Y (septiembre de 2000). «Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages». Blood 96 (5): 1723-32. PMID 10961870. Archivado desde el original el 15 de septiembre de 2019. Consultado el 13 de diciembre de 2010. 
  • Axelsson J, Bergsten A, Qureshi AR, Heimbürger O, Bárány P, Lönnqvist F, Lindholm B, Nordfors L, Alvestrand A, Stenvinkel P (febrero de 2006). «Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance». Kidney Int. 69 (3): 596-604. PMID 16395259. doi:10.1038/sj.ki.5000089. 
  • Asensio C, Cettour-Rose P, Theander-Carrillo C, Rohner-Jeanrenaud F, Muzzin P (mayo de 2004). «Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis». Endocrinology 145 (5): 2206-13. PMID 14962997. doi:10.1210/en.2003-1679. 
  • Lee JH, Bullen JW, Stoyneva VL, Mantzoros CS (marzo de 2005). «Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia». Am. J. Physiol. Endocrinol. Metab. 288 (3): E625-32. PMID 15522996. doi:10.1152/ajpendo.00184.2004. 
  • Valsamakis G, McTernan PG, Chetty R, Al Daghri N, Field A, Hanif W, Barnett AH, Kumar S (abril de 2004). «Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines». Metab. Clin. Exp. 53 (4): 430-4. PMID 15045687. doi:10.1016/j.metabol.2003.11.022. 
  • McTernan PG, McTernan CL, Chetty R, Jenner K, Fisher FM, Lauer MN, Crocker J, Barnett AH, Kumar S (mayo de 2002). «Increased resistin gene and protein expression in human abdominal adipose tissue». J. Clin. Endocrinol. Metab. 87 (5): 2407. PMID 11994397. doi:10.1210/jc.87.5.2407. 
  • Duman BS, Turkoglu C, Gunay D, Cagatay P, Demiroglu C, Buyukdevrim AS (agosto de 2003). «The interrelationship between insulin secretion and action in type 2 diabetes mellitus with different degrees of obesity: evidence supporting central obesity». Diabetes Nutr. Metab. 16 (4): 243-50. PMID 14768774. 
  • Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS (noviembre de 2002). «A central role for JNK in obesity and insulin resistance». Nature 420 (6913): 333-6. PMID 12447443. doi:10.1038/nature01137. Archivado desde el original el 21 de abril de 2008. 
  • Rajala MW, Qi Y, Patel HR, Takahashi N, Banerjee R, Pajvani UB, Sinha MK, Gingerich RL, Scherer PE, Ahima RS (julio de 2004). «Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting». Diabetes 53 (7): 1671-9. PMID 15220189. doi:10.2337/diabetes.53.7.1671. 
  • Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ (octubre de 2003). «Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance». Eur. J. Endocrinol. 149 (4): 331-5. PMID 14514348. doi:10.1530/eje.0.1490331. 
  • Smith SR, Bai F, Charbonneau C, Janderová L, Argyropoulos G (julio de 2003). «A promoter genotype and oxidative stress potentially link resistin to human insulin resistance». Diabetes 52 (7): 1611-8. PMID 12829623. doi:10.2337/diabetes.52.7.1611. 
  • Fujinami A, Obayashi H, Ohta K, Ichimura T, Nishimura M, Matsui H, Kawahara Y, Yamazaki M, Ogata M, Hasegawa G, Nakamura N, Yoshikawa T, Nakano K, Ohta M (enero de 2004). «Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes». Clin. Chim. Acta 339 (1-2): 57-63. PMID 14687894. doi:10.1016/j.cccn.2003.09.009. 
  • McTernan PG, Fisher FM, Valsamakis G, et al. (diciembre de 2003). «Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes». J. Clin. Endocrinol. Metab. 88 (12): 6098-106. PMID 14671216. doi:10.1210/jc.2003-030898. 
  • Tjokroprawiro A (2006). «New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer)». Acta Med Indones 38 (3): 160-6. PMID 17119268. 
  • Fain JN, Cheema PS, Bahouth SW, Lloyd Hiler M (enero de 2003). «Resistin release by human adipose tissue explants in primary culture». Biochem. Biophys. Res. Commun. 300 (3): 674-8. PMID 12507502. doi:10.1016/S0006-291X(02)02864-4. 
  • Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Estrada E, Seip R, Orlova C, Mantzoros CS (octubre de 2003). «Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects». J. Clin. Endocrinol. Metab. 88 (10): 4848-56. PMID 14557464. doi:10.1210/jc.2003-030519. 
  • Nagaev I, Smith U (julio de 2001). «Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle». Biochem. Biophys. Res. Commun. 285 (2): 561-4. PMID 11444881. doi:10.1006/bbrc.2001.5173. 
  • Heilbronn LK, Rood J, Janderova L, Albu JB, Kelley DE, Ravussin E, Smith SR' (abril de 2004). «Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects». J. Clin. Endocrinol. Metab. 89 (4): 1844-8. PMID 15070954. doi:10.1210/jc.2003-031410. 
  • Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O'Rahilly S (octubre de 2001). «Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans». Diabetes 50 (10): 2199-202. PMID 11574398. doi:10.2337/diabetes.50.10.2199. 
  • Way JM, Görgün CZ, Tong Q, Uysal KT, Brown KK, Harrington WW, Oliver WR Jr, Willson TM, Kliewer SA, Hotamisligil GS (julio de 2001). «Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists». J. Biol. Chem. 276 (28): 25651-3. PMID 11373275. doi:10.1074/jbc.C100189200. 

web.archive.org